Increasing survival time after AIDS in Italy: The role of new combination antiretroviral therapies

AIDS

Volumn 13, Issue 2, 1999, Pages 249-255

  Pezzotti, Patrizio ^a   Napoli, Pier Angela ^a   Acciai, Serenella ^b   Boros, Stefano ^a   Urciuoli, Roberta ^a   Lazzeri, Vera ^b   Rezza, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Tuscany Regional Health Agency   (Italy)

Author keywords

Antiretroviral therapy; Epidemiology; Natural history; Surveillance

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; FEMALE; HUMAN; HUMAN CELL; ITALY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HIV PROTEASE INHIBITORS; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; SURVIVORS; TIME FACTORS;

EID: 0032971613     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199902040-00013     Document Type: Article

References (29)

1. CDSC/PHLS: Changes in the incidence of AIDS and in AIDS deaths: the effects of antiretroviral treatment CDR Wkly 1997, 7:381.
2. Moulon Y, Alfandari S, Valette M, et al.: Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997, 11;F101-F105.
3. Centers for Disease Control and Prevention: Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR 1997, 46:165-173.
4. Hogg RS, O'Shaughnessy MV, Gataric N, et al.: Decline in deaths from AIDS due to new antiretrovirals [letter]. Lancet 1997, 349:1294.
5. Delta Coordinating Committee: Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1096, 348:283-291.
6. Cameron DW, Heath-Chiozzi M, Kravcik S, Mills R, Potthoff A, Henry D: Prolongation of life and prevention of AIDS complications in advanced HIV immunodeficiency with ritonavir: update. XI International Conference on AIDS. Vancouver, July 1996 [abstract MoB411].
7. Hammer SM, Squires KF, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997, 337:725-733.
8. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997, 11:1731-1738.
9. Palella FJ, Delaney KM, Morman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
10. Egger M, Hirschel B, Francioli P, et al.: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 1997, 315:1194-1199.
11. Mocroft A, Vella S. Benfield IL, et al.: Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998, 352:1725-1730.
12. Hamilton JD, Hartigan PM, Simberkoff MS, et al.: A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. N Engl J Med 1992, 326:437-443.
13. Lalezari J, Haubrich R, Burger HU, et al.: Improved survival and decreased progression of HIV in patients treated with saquinavir (Invirase™, SQV) plus HIVID (Zalcitabine, ddC). IX International Conference on AIDS. Vancouver, July 1996 [abstract LBB6033].
14. Abeni D, Perucci CA, Gruppo Collaborativo Sorveglianza AIDS del Lazio; Sopravvivenza dalla diagnosi di AIDS, Roma e Lazio 1982-1992. Ital AIDS 1993, 4:16-25.
15. Mocroft A, Youle M, Morcinek J, et al.: Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. BMJ 1997, 314:409-413.
16. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A: Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994, 271:1083-1087.
17. Rogers PA, Whitmore-Overton SE, Evans BG, Allardice GM, Noone A: Survival of adults with AIDS in the United Kingdom. CDR Wkly 1997, 7:93-100.
18. Barchielli A, Acciai S, Lazzeri V, Buiatti E: Survival after AIDS diagnosis in Tuscany (Italy), 1985-1992. Fur J Epidemiol 1997, 13:125-132.
19. Centro Operative AIDS, Istituto Superiore di Sanità: Aggiornamento dei casi di AIDS notificati in Italia al 31 Dicembre 1997. Notiziario 1st Super Sanità 1998, 11 (suppl 1):pages 1-12.
20. Ancelle-Park R: Expanded European AIDS case definition [letter]. Lancet 1993, 341:441.
21. Napoli PA, Dorrucci M, Serraino D, et al.: Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii pneumonia (PCP) before AIDS diagnosis in Italy. Eur J Epidemiol 1998, 14:41-47.
22. Anonymous: State-of-the-art conference on azidothymidine therapy for early HIV infection. Am J Med 1990, 89:335-344.
23. Sande MA, Carpenter CCJ, Cobbs CG, Holmes KK, Sanford JP: Antiretroviral therapy for adult HIV-infected patients. JAMA 1993, 270:2583-2589.
24. Carpenter CCJ, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA 1996, 276:146-154.
25. Carpenter CCJ, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997, 277:1962-1969.
26. Collett D: Modelling Survival Data in Medical Research. London: Chapman and Hall; 1994.
27. Torres RA, Barr M: Impact of combination therapy for HIV infection on inpatient census. N Engl J Med 1997, 336:1531-1532.
28. Dorrucci M, Pezzotti P, Phillips AN, Alliegro MB, Rezza G, HIV Italian Seroconversion Study: Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. AIDS 1997, 11:461-467.
29. Glesby MJ, Hoover DR: Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med 1996, 124:999-1005.